Hematology Will Play - Roche Moves Closer to High-Growth Core Lab Market Segment

Hematology Will Play - Roche Moves Closer to High-Growth Core Lab Market Segment

This blog updates developments in the markets for hematology and core lab diagnostics comprehensively covered in the Kalorama Information reports The World Market for Hematology and The Worldwide Market for In Vitro Diagnostic Tests, 9 th Edition.

True to its name, Roche’s Bloodhound technology is on the trail of a conspicuously high-growth market segment in hematology testing. Digital cell imaging and morphology analysis is a significant addition to conventional core lab hematology capabiliti...


Pillars of U.S. Physician Office Testing - Complete Blood Count (CBC)

Pillars of U.S. Physician Office Testing - Complete Blood Count (CBC)

The ready-made popularity of CLIA-waived tests has not crowded out more complex tests from the physician office laboratory (POL) market. Some diagnostic tools are well-suited for placement across the spectrum: from the core lab workstations of central labs to the bench top of a physician practice. Performed on an impedance- or optical-based hematology analyzer, the complete blood count (CBC) is easily situated within a POL through compact, bare-bones models requiring no floor space and other inn...

  • by esalazar@marketresearch.com
  • May 9 2014
  • hematology


Sysmex Continues Its Push into the U.S. Hematology Market

Sysmex Continues Its Push into the U.S. Hematology Market

Line item growth of 40% from a company heavily involved in the U.S. hematology market is a startling figure - and precisely what Sysmex Corporation accomplished in the 2013 calendar year. Sysmex hematology sales to the Americas increased from approximately 23.5 billion yen in the 2012 calendar year to 33.0 billion yen in 2013. The significant growth was attributed to several factors :

In the United States, in addition to rising instrument sales, an increase in the installed instrument base led...


Hematology Middleware Creates a New Front for Competition

Hematology Middleware Creates a New Front for Competition

Middleware and information technology (IT) services earn revenue for hematology companies, but are also crucial competitive factors in securing clients in the developed world. Hematology players in North America and Europe sell to consolidated markets with established instrument bases and where platform features such as middleware are becoming a primary tool of competition to wrest away market share. In a period of relatively high parity between major analyzer platforms in terms of capabilities,...


Hematology Industry Focus: Beckman Coulter

Hematology Industry Focus: Beckman Coulter

Playing second fiddle to Sysmex on the global stage in hematology, Beckman Coulter remains the U.S. market leader and a major innovator in hematology workstation solutions for increasingly cost-pressured clinical lab clients.

As part of the recently published The World Market for Hematology , Kalorama Information investigated Beckman Coulter’s position in the IVD segment and the steps the company is taking to shape its future role.

By any indicator, Beckman Coulter lost its leading global ma...

  • by esalazar@marketresearch.com
  • November 20 2013
  • hematology


A Complete Count of the Global Hematology Market

A Complete Count of the Global Hematology Market

Hematology testing stands far from the IVD market’s most ambitious clinical frontiers and, without significant expansion in clinical applications, is bound by gradual trends in patient population and available healthcare infrastructure (lab, physician, and other clinical clients). Lab industries in the developed world are largely undergoing consolidation and cost-cutting and resident patient populations are not growing fast enough - either in absolute numbers or testing intensity - to drive hema...


Digital Imaging for Hematology Coming Into Focus

Digital Imaging for Hematology Coming Into Focus

The leader in differential imaging for hematology can expect a more crowded market space in the coming years. CellaVision AB commands an intriguing, peripheral IVD market sub-segment aimed at eliminating one of the most costly and time-consuming procedures: the manual differential. The company’s products effectively replace manual microscopy and cell counting with automated systems that use neural networking and algorithms to classify blood cell populations based on image-captured and archived m...


On the Prospect of CLIA-Waived Differentials

On the Prospect of CLIA-Waived Differentials

Hematology testing such as complete blood counts (CBC) and differentials is customarily the domain of clinical laboratories. Instrument automation and the innovation of compact, streamlined models, however, has made such testing possible outside of the lab. Today’s hematology analyzers range from autoloaded, high-throughput and flow cytometry-capable in the lab to closed-menu, benchtop and ease-of-use at a clinic or physician’s office. While labs in the developing world continue to fuel market g...


Hematology Industry Mapping and Its Boundaries

Hematology Industry Mapping and Its Boundaries

Laboratory hematology is largely synonymous with its leading vendors such as Beckman Coulter and Sysmex. High order volumes among such vendors are ensured through established relationships with premium clients such as care networks, other large healthcare institutions, clinical laboratories, and reference labs. The profile of companies such as Beckman Coulter and Abbott Diagnostics is also higher due to the breadth of their product offering, particularly within the core lab - clinical chemistry,...